Warfarin

Routes
Oral (PO)
Half-Life (t½)
PO: 40h
Formula
C19H16O4
Molecular Weight
308.33 g/mol
PubChem CID
54678486
Aliases
Coumadin, Jantoven

Pharmacological Mechanism

Inhibits vitamin K epoxide reductase (VKOR) → depletes reduced vitamin K → prevents γ-carboxylation of factors II, VII, IX, X + proteins C/S. Narrow therapeutic index + massive interaction list + dietary K variability → DOACs (apixaban, rivaroxaban) now preferred for non-valvular indications.

Half-Life & Elimination Curve (PO: 40h)

100%50%25%12.5%0%0h0×t½40h1×t½3.3d2×t½5d3×t½6.7d4×t½8.3d5×t½0×t½ (0h): 100% remaining (~0.526 mg/L)1×t½ (40h): 50% remaining (~0.263 mg/L)2×t½ (3.3d): 25% remaining (~0.132 mg/L)3×t½ (5d): 12.5% remaining (~65.8 µg/L)4×t½ (6.7d): 6.3% remaining (~32.9 µg/L)5×t½ (8.3d): 3.1% remaining (~16.4 µg/L)
Plasma (PO)t½ Decay (40h)
  • 0×t½0h100% (0.526 mg/L)
  • 1×t½40h50% (0.263 mg/L)
  • 2×t½3.3d25% (0.132 mg/L)
  • 3×t½5d12.5% (65.8 µg/L)
  • 4×t½6.7d6.3% (32.9 µg/L)
  • 5×t½8.3d3.1% (16.4 µg/L)
Elimination t½40h (PO)
Rate Constant (ke)0.0173 h⁻¹
Time to Peak (Tmax)3.01h
Est. Peak (Cmax)0.526 mg/L
Clearance (CL)0.139 L/h
97% Washout (5×t½)8.3d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References